Book An Appointment

Cancer Early Detection Screening Packages

Multi-Cancer Early Detection Screening Packages

  • Our Multi-Cancer Early Detection (MCED) screening packages use advanced blood tests to look for signals associated with multiple types of cancer. Explore our MCED tests, LucenceINSIGHT® and SPOT-MAS, for an additional approach to early cancer detection.

Single-Cancer Early Detection Screening Tests

  • Our single-cancer tests use advanced blood tests to look for signals associated with specific types of cancer. Explore LUNGClear and GASTROClear for targeted screening options that complement routine cancer screening.
Learn More

Cancer Early Detection Screening at a Glance

Explore our available tests at a glance, including what each screens for and how they can complement your routine cancer screening.

LucenceINSIGHT®
By Lucence		 SPOT-MAS
By Gene Solutions		 LUNGClear / GASTROClear
By Mirxes
Types of Cancers ScreenedUp to 50 cancer types10 cancer types1 cancer type per test
Screening Method

Looks for ctDNA, ctRNA* and viral DNA* released by cancer cells into the blood.

Examines the size and shape of these fragments to flag patterns associated with cancer.

Looks for ctDNA released by cancer cells into the blood.

Examines the size, shape, and chemical markers (methylation) of these fragments to flag patterns associated with cancer.

Looks for microRNA released by both normal and cancer cells, into the blood.

Measures a panel of microRNAs and combines them into a single risk score.
Screening Accuracy**
  • 99% Specificity
  • 100% Positive Predictive Value
  • 88% Tumor Localisation Accuracy
  • Boosted detection with 12.5% relative increase in sensitivity for detection of lung, colon and breast cancer with ctDNA + ctRNA1
  • 70.8% Sensitivity
  • 99.7% Specificity
  • 39.5% Positive Predictive Value
  • 99.9% Negative Predictive Value
  • 52.9% Tumour-of-origin Predictive Value2

LUNGClear3

  • 74% Sensitivity, 78% Specificity
    (when intermediate and high-risk results are deemed positive)
  • 34% Sensitivity, 97% Specificity
    (when high-risk results are deemed positive)

GASTROClear4

  • >80% Sensitivity

* For certain cancer types

** Figures are adapted from each provider’s own studies, which used different patient groups and cancer types. Differences between the numbers may be due to study design rather than test performance.

References
Information last accessed on 14 Oct 2026. Please refer to the provider’s official website for the latest updates.

  1. LucenceINSIGHT® | lucence. (2025). Lucence. https://www.lucence.com/solutions/lucence-insight
  2. SPOT-MAS ctDNA screening for early cancer detection. (2023). Gene Solutions Singapore. https://genesolutions.com/our-test/spot-mas
  3. LUNGClear™: A microRNA-powered blood test for early detection of lung cancer. (2025, November 3). [Technical report]. https://www.parkwaylabs.com.sg/docs/parkwaylablibraries/test-catalogues/lungclear-physician-(a4)-brochure.pdf?sfvrsn=c1d808c2_1
  4. Agency for Science, Technology, and Research (A*STAR), National University Hospital, Tan Tock Seng Hospital, & MiRXES. (2023). GASTROClear physician brochure: Molecular blood test for early detection of gastric cancer. https://gastroclear.mirxes.com/wp-content/uploads/2023/03/GASTROClear-physician-brochure_2021.pdf

Multi-Cancer Early Detection Screening Packages

While we strive to keep our pricing current, we encourage you to connect with our team to confirm current details.

Single-Cancer Early Detection Tests

Single-Cancer Early Detection Tests LUNGClear GASTROClear
SGD (exclusive of GST) $320 $320
Types of Cancers Screened Lung cancer Gastric cancer

While we strive to keep our pricing current, we encourage you to connect with our team to confirm current details.

Book Your Health Screening Today

Taking care of your health starts with one simple step. Whether you are planning a routine check-up or a comprehensive health screening, our team is here to guide you with personalised care and a seamless booking experience.

Request An Appointment

Please fill out this form for our team to get in touch with you to schedule your consultation. We will get back to you the next working day. For urgent requests, please WhatsApp us or call the centre.

Frequently Asked Questions

Health screenings typically operate on a self-pay and claim basis, where applicable. Your health screening or imaging test(s) may be covered or be eligible for corporate rates through insurance or corporate agreements. Please consult your company's HR department or insurance provider for further details.

HbA1C is a diagnostic tool for diabetes, offering information on blood glucose control over the past three months by measuring sugar molecules attached to red blood cells. Additionally, a non-fasting random blood glucose test is performed. It is important to recognise that the normal range for random blood glucose differs from that of fasting blood glucose.

If there are abnormal results in the random blood glucose or HbA1C tests, a fasting blood glucose test may be required to confirm a diagnosis of diabetes or prediabetes.

  • Risk category assignment – What are the risk factors for disease?
  • Early disease assessment – Do you exhibit any of the early warning signs or symptoms of disease?
  • Modifiable disease contributor assessment – Which of the risk factors can be improved with lifestyle changes?

You are advised to conduct your medical check up 2 weeks after any vaccination.

If you have recently received the COVID-19 vaccination, you are advised to schedule your mammogram or breast ultrasound appointment at least 6 weeks after receiving the vaccination.

You do not have to delay your health screening check up because of a recent infection.

Blood tests: Some inflammatory markers may be elevated after an infection and the results can be read in the context of a recent infection.

Complications from a COVID-19 infection may also be detected and should be followed up. High sensitivity CRP for cardiac risk stratification would not be suitable for those who have had COVID-19 in the last 1 month.

Chest X-ray: May show infective changes when done after a recent COVID-19 infection and abnormalities should be followed up.

It is not advisable to do health screening if you are pregnant as your gynaecologist would have conducted the necessary prenatal screening for you.

During pregnancy:

  • Urea and uric acid will decrease during the 1st trimester.
  • By the 2nd trimester, the albumin, potassium, protein and sodium level will decrease while the creatinine level increases.
  • Glucose and cholesterol levels will increase, contributing to a risk of gestational diabetes, which can increase the risk of developing high blood pressure, such as preeclampsia.

Hence, results will not be accurately presented.

You can use your Medisave funds to pay for various diagnostic tests, provided you meet the eligibility requirements and stay within the set limits. For full details, please check the Central Provident Fund (CPF) website.

  1. Cashless service
  2. Medisave: Please be advised that full payment is required on the day of your visit when using Medisave. Once approved by the Central Provident Fund (CPF), reimbursement will be processed within 30 business days.